日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants

ChAdOx1 nCoV-19疫苗可诱导产生对SARS-CoV-2病毒变种具有交叉中和活性的单克隆抗体

Jeffrey Seow ,Carl Graham ,Sadie R Hallett ,Thomas Lechmere ,Thomas J A Maguire ,Isabella Huettner ,Daniel Cox ,Hataf Khan ,Suzanne Pickering ,Rebekah Roberts ,Anele Waters ,Christopher C Ward ,Christine Mant ,Michael J Pitcher ,Jo Spencer ,Julie Fox ,Michael H Malim ,Katie J Doores

HIV-1 Vpr Induces Widespread Transcriptomic Changes in CD4+ T Cells Early Postinfection

HIV-1 Vpr 在感染后早期诱导 CD4+ T 细胞发生广泛的转录组变化

Hélène Bauby #, Christopher C Ward #, Rupert Hugh-White, Chad M Swanson, Reiner Schulz #, Caroline Goujon #, Michael H Malim #

An increase in glycoprotein concentration on extracellular virions dramatically alters vaccinia virus infectivity and pathogenesis without impacting immunogenicity

细胞外病毒颗粒上糖蛋白浓度的增加会显著改变痘苗病毒的感染性和致病性,但不会影响其免疫原性。

Monticelli, Stephanie R; Bryk, Peter; Brewer, Matthew G; Aguilar, Hector C; Norbury, Christopher C; Ward, Brian M

Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection

人类 MX2 是干扰素诱导的 HIV-1 感染进入后抑制剂

Caroline Goujon, Olivier Moncorgé, Hélène Bauby, Tomas Doyle, Christopher C Ward, Torsten Schaller, Stéphane Hué, Wendy S Barclay, Reiner Schulz, Michael H Malim